BLOC1S1 and diabetic kidney disease: Treatment of STZ-DKD mice with sh-GN5L1AAV reduced tubulointerstitial injury and knockdown of GCN5L1 in TECs similarly reduced epithelial-to-mesenchymal transition (EMT) and inflammation, suggesting that targeting GCN5L1 may be an attractive therapeutic option for DKD.